Bénéfices
| Q4 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 4.340 | ||
| Révision: | $149.35M | $160.84M | — |
| Q3 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.880 | 2.840 | 0.9600 |
| Révision: | $130.58M | $146.50M | $7.17M |
| Q2 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.770 | 2.710 | 0.9400 |
| Révision: | $135.86M | $151.23M | $1.02M |
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.130 | 1.620 | 0.4900 |
| Révision: | $135.81M | $157.92M | $3.51M |
